Skip to main content
Top
Published in: Neurological Sciences 4/2014

01-04-2014 | News and Views

From the liver to the brain: manganese matters

Focus on cirrhosis-related Parkinsonism

Authors: Andrea Mignarri, Antonio Federico

Published in: Neurological Sciences | Issue 4/2014

Login to get access

Excerpt

In this issue, an original article by Maffeo and colleagues [1] deals with chronic acquired hepatocerebral degeneration (CAHD), a disorder linking cirrhosis to Parkinsonism through brain accumulation of manganese (Mn). The authors studied a population of 90 subjects with cirrhosis: 26 out of 90 showed MRI pallidal T1 hyperintense signal suggestive of Mn storage, 7 of whom had CAHD. A long-term neurological and neuroradiological follow up was performed, including evaluation of response to orthotopic liver transplantation (OLT). The study remarks three main concepts. First, cerebral accumulation of Mn is necessary but not sufficient for CAHD, and cannot be considered predictive of CAHD: indeed, brain MRI often reveals Mn storage in cirrhotic patients without neurological manifestations even at long-term follow up. Second, blood Mn levels do not seem to reflect brain Mn deposits. Third, OLT may lead to disappearance of CAHD and/or MRI pallidal T1 hyperintensity. …
Literature
1.
go back to reference Maffeo E, Montuschi A, Stura G, Giordana MT (2013) Chronic acquired hepatocerebral degeneration, pallidal T1 MRI hyperintensity and manganese in a series of cirrhotic patients. Neurol Sci (Epub ahead of print) Maffeo E, Montuschi A, Stura G, Giordana MT (2013) Chronic acquired hepatocerebral degeneration, pallidal T1 MRI hyperintensity and manganese in a series of cirrhotic patients. Neurol Sci (Epub ahead of print)
2.
go back to reference Victor M, Adams RD, Cole M (1965) The acquired (non-Wilsonian) type of chronic hepatocerebral degeneration. Medicine (Baltimore) 44(5):345–396CrossRef Victor M, Adams RD, Cole M (1965) The acquired (non-Wilsonian) type of chronic hepatocerebral degeneration. Medicine (Baltimore) 44(5):345–396CrossRef
3.
go back to reference Krieger D, Krieger S, Jansen O, Gass P, Theilmann L, Lichtnecker H (1995) Manganese and chronic hepatic encephalopathy. Lancet 346(8970):270–274PubMedCrossRef Krieger D, Krieger S, Jansen O, Gass P, Theilmann L, Lichtnecker H (1995) Manganese and chronic hepatic encephalopathy. Lancet 346(8970):270–274PubMedCrossRef
4.
go back to reference Burkhard PR, Delavelle J, Du Pasquier R, Spahr L (2003) Chronic parkinsonism associated with cirrhosis: a distinct subset of acquired hepatocerebral degeneration. Arch Neurol 60(4):521–528PubMedCrossRef Burkhard PR, Delavelle J, Du Pasquier R, Spahr L (2003) Chronic parkinsonism associated with cirrhosis: a distinct subset of acquired hepatocerebral degeneration. Arch Neurol 60(4):521–528PubMedCrossRef
5.
go back to reference Tryc AB, Goldbecker A, Berding G, Rümke S, Afshar K, Shahrezaei GH, Pflugrad H, Barg-Hock H, Strassburg CP, Hecker H, Weissenborn K (2013) Cirrhosis-related Parkinsonism: prevalence, mechanisms and response to treatments. J Hepatol 58(4):698–705PubMedCrossRef Tryc AB, Goldbecker A, Berding G, Rümke S, Afshar K, Shahrezaei GH, Pflugrad H, Barg-Hock H, Strassburg CP, Hecker H, Weissenborn K (2013) Cirrhosis-related Parkinsonism: prevalence, mechanisms and response to treatments. J Hepatol 58(4):698–705PubMedCrossRef
6.
go back to reference Butterworth RF (2013) Parkinsonism in cirrhosis: pathogenesis and current therapeutic options. Metab Brain Dis 28(2):261–267PubMed Butterworth RF (2013) Parkinsonism in cirrhosis: pathogenesis and current therapeutic options. Metab Brain Dis 28(2):261–267PubMed
7.
go back to reference Quadri M, Federico A, Zhao T, Breedveld GJ, Battisti C, Delnooz C, Severijnen LA, Di Toro Mammarella L, Mignarri A, Monti L, Sanna A, Lu P, Punzo F, Cossu G, Willemsen R, Rasi F, Oostra BA, van de Warrenburg BP, Bonifati V (2012) Mutations in SLC30A10 cause parkinsonism and dystonia with hypermanganesemia, polycythemia, and chronic liver disease. Am J Hum Genet 90(3):467–477PubMedCentralPubMedCrossRef Quadri M, Federico A, Zhao T, Breedveld GJ, Battisti C, Delnooz C, Severijnen LA, Di Toro Mammarella L, Mignarri A, Monti L, Sanna A, Lu P, Punzo F, Cossu G, Willemsen R, Rasi F, Oostra BA, van de Warrenburg BP, Bonifati V (2012) Mutations in SLC30A10 cause parkinsonism and dystonia with hypermanganesemia, polycythemia, and chronic liver disease. Am J Hum Genet 90(3):467–477PubMedCentralPubMedCrossRef
8.
go back to reference Di Toro Mammarella L, Mignarri A, Battisti C, Monti L, Bonifati V, Rasi F, Federico A (2014) Two-year follow-up after chelating therapy in a patient with adult-onset parkinsonism and hypermanganesaemia due to SLC30A10 mutations. J Neurol 261(1):227–228CrossRef Di Toro Mammarella L, Mignarri A, Battisti C, Monti L, Bonifati V, Rasi F, Federico A (2014) Two-year follow-up after chelating therapy in a patient with adult-onset parkinsonism and hypermanganesaemia due to SLC30A10 mutations. J Neurol 261(1):227–228CrossRef
Metadata
Title
From the liver to the brain: manganese matters
Focus on cirrhosis-related Parkinsonism
Authors
Andrea Mignarri
Antonio Federico
Publication date
01-04-2014
Publisher
Springer Milan
Published in
Neurological Sciences / Issue 4/2014
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-014-1665-0

Other articles of this Issue 4/2014

Neurological Sciences 4/2014 Go to the issue